Pioneering Pain-Free Orthodontic Care: Sakowitz Smiles Orthodontics Introduces Dental Pain Eraser

Pioneering Pain-Free Orthodontic Care: Sakowitz Smiles Orthodontics Introduces Dental Pain Eraser

September 15, 2023 Editor 0

Pioneering Pain-Free Orthodontic Care: Sakowitz Smiles Orthodontics Introduces Dental Pain Eraser

Pioneering Pain-Free Orthodontic Care: Sakowitz Smiles Orthodontics Introduces Dental Pain EraserTop Industry Innovation Award for 2023 Recognizes the Dental Pain Eraser’s Pioneering Pain-Free Orthodontic Approach

Pioneering Pain-Free Orthodontic Care: Sakowitz Smiles Orthodontics Introduces Dental Pain Eraser
Award Winning Dental Pain Eraser

The Synapse Dental Pain Eraser won the prestigious 2023 Orthodontic Innovator Award at the American Association of Orthodontists annual meeting.

Sakowitz Smiles Orthodontics is taking a revolutionary step in the world of orthodontic care by incorporating cutting-edge technology known as the Dental Pain Eraser. This innovation is poised to transform the orthodontic treatment experience, making it more comfortable and virtually pain-free for patients.

In the realm of healthcare, orthodontists and dentofacial orthopedists often serve as the first professionals to introduce younger patients to real, lasting physical discomfort. However, Sakowitz Smiles Orthodontics believes that this should not be the defining image of orthodontic care for children and adults alike.

“We are committed to creating positive memories for our patients,” says Dr. Scott Sakowitz, founder and lead orthodontist at Sakowitz Smiles Orthodontics. “We understand that orthodontic treatment can be challenging, especially for children. Our goal is to ensure that the pain associated with orthodontic procedures becomes a thing of the past.”

“The Dental Pain Eraser is a groundbreaking technology that allows us to provide immediate relief from soft tissue pain and general orthodontic discomfort. Applying this remarkable device for just 10-15 seconds along the root surface can dramatically reduce the discomfort experienced during orthodontic visits. From wire activations to separator placements to aligner adjustments, every step of the journey now feels significantly more comfortable.”

“The relief is real, and it’s transformative,” adds Dr. Sakowitz. “The Dental Pain Eraser isn’t just remarkably effective; it’s possibly the fastest, easiest, and only drug-free method for reducing soft tissue pain in the orthodontic arena.”

In a recent study published in the Journal of Clinical Orthodontics, 84% of the subjects who used the Dental Pain Eraser experienced pain relief in less than 2 minutes. An astonishing 44 out of 45 subjects reported experiencing orthodontic pain relief, often lasting for at least 48 hours.

The American Association of Orthodontists recognized the significant impact of the Dental Pain Eraser by awarding it the top industry innovation award for 2023. This prestigious accolade underscores the device’s effectiveness in making orthodontic treatment more comfortable and pain-free.

The introduction of the Dental Pain Eraser at Sakowitz Smiles Orthodontics signifies their commitment to delivering the highest level of care to their patients. It is a significant step toward making orthodontic treatment a more comfortable and pain-free experience.

For more information about Sakowitz Smiles Orthodontics and the Dental Pain Eraser, please visit https://orlandoorthodontics.com or contact them at (407) 627-1187.

About Sakowitz Smiles Orthodontics

Sakowitz Smiles Orthodontics is a leading private orthodontic practice dedicated to providing exceptional orthodontic care for patients of all ages. Dr. Sakowitz and the team at Sakowitz Smiles Orthodontics are committed to creating beautiful smiles while ensuring a comfortable and pain-free journey for every patient.

Contact Information:

Leidy Collado

Practice Manager

[email protected]

4076271187

Scott Sakowitz

Owner, Orthodontist

[email protected]

4076271187

Related Images


Award Winning Dental Pain Eraser

Award Winning Dental Pain Eraser

The Synapse Dental Pain Eraser won the prestigious 2023 Orthodontic Innovator Award at the American Association of Orthodontists annual meeting.

Original Source:

Pioneering Pain-Free Orthodontic Care: Sakowitz Smiles Orthodontics Introduces Dental Pain Eraser

The post Pioneering Pain-Free Orthodontic Care: Sakowitz Smiles Orthodontics Introduces Dental Pain Eraser appeared first on AESTHETIC NEWS.

Board-Certified Plastic Surgeon Dr. Robert Kratschmer Discusses Shifts in Plastic Surgery Trends Amidst Rising Semaglutide Use

Board-Certified Plastic Surgeon Dr. Robert Kratschmer Discusses Shifts in Plastic Surgery Trends Amidst Rising Semaglutide Use

September 15, 2023 Editor 0

Board-Certified Plastic Surgeon Dr. Robert Kratschmer Discusses Shifts in Plastic Surgery Trends Amidst Rising Semaglutide Use

Board-Certified Plastic Surgeon Dr. Robert Kratschmer Discusses Shifts in Plastic Surgery Trends Amidst Rising Semaglutide UseThe Impact of Semaglutide on Cosmetic Procedures: An Insight into Emerging Trends

Board-Certified Plastic Surgeon Dr. Robert Kratschmer Discusses Shifts in Plastic Surgery Trends Amidst Rising Semaglutide Use
Stock Photo ID: 561920116. Shutterstock. Africa Studio. 2023

Mature woman’s body before and after weight loss on white background. Health care and diet concept.

Over the last few years, the landscape of plastic surgery has seen remarkable changes. Dr. Robert Kratschmer, a board-certified plastic surgeon based in Houston, sheds light on how the popularization of the drug Semaglutide is affecting patient choices in cosmetic procedures.

“Two years ago, liposuction and fat transfer were the procedures that dominated patient interest,” says Dr. Kratschmer. “While they remain popular, the rise of Semaglutide for weight management has led to a notable increase in other procedures, like panniculectomy, thigh lift, arm lift, and neck lift surgeries.”

Semaglutide, originally developed for the treatment of type 2 diabetes, has been growing in prominence for its off-label use in weight management. This has had ripple effects in the plastic surgery community.

Dr. Kratschmer explains, “Semaglutide has offered a non-surgical option for weight loss, which is changing the kinds of procedures people are seeking. Many of my patients have successfully used it for weight loss, but are then left with excess skin that they want to address. As a result, we’re seeing a considerable uptick in surgeries designed to remove excess skin and contour the body.”

This shift is significant, not only for prospective patients but also for the medical community at large. The rising interest in these procedures suggests that people are becoming increasingly conscious of comprehensive body transformations that focus on both weight loss and body contouring.

“Every medical advancement impacts patient choices,” Dr. Kratschmer says. “As physicians, we must adapt and continue to offer the best care based on emerging trends and technologies. It’s an exciting time in the field of plastic surgery, and I’m eager to see how this evolves in the years to come.”

For those considering plastic surgery, Dr. Kratschmer advises consultations to discuss individual needs and options. “Patient care is always our utmost priority. Our consultations aim to guide patients through the variety of choices now available, so they can make informed decisions that align with their goals,” he concludes.

To learn more about Dr. Robert Kratschmer and his practice, please visit SiliconeMD.com.

About Dr. Robert Kratschmer

Dr. Robert Kratschmer is a board-certified plastic surgeon with over 20 years of experience. Based in the Greater Houston area, he specializes in a wide range of cosmetic procedures and is committed to providing exceptional care for his patients.

Contact Information:

Amber K.

Practice Manager

[email protected]

2813178179

Original Source:

Board-Certified Plastic Surgeon Dr. Robert Kratschmer Discusses Shifts in Plastic Surgery Trends Amidst Rising Semaglutide Use

The post Board-Certified Plastic Surgeon Dr. Robert Kratschmer Discusses Shifts in Plastic Surgery Trends Amidst Rising Semaglutide Use appeared first on AESTHETIC NEWS.

ZetrOZ Systems’ sam Technology Can Help College Athletes Recover From Injury

ZetrOZ Systems’ sam Technology Can Help College Athletes Recover From Injury

September 14, 2023 Editor 0

ZetrOZ Systems’ sam Technology Can Help College Athletes Recover From Injury

ZetrOZ Systems’ sam Technology Can Help College Athletes Recover From InjurySustained acoustic medicine provides proven soft tissue healing via ZetrOZ’s patented wearable ultrasound unit.

Saturday afternoons in autumn mean college sports and the return of amateur athletes to their fields, gyms and stadiums. Student-athletes can stay healthier, heal more easily from soft-tissue injuries, and return to their sport more quickly with ZetrOZ Systems‘ sustained acoustic medicine (sam®) technology, now covered by secondary insurance for many colleges.  

On average, more than 200,000 athletes in major National Collegiate Athletic Association (NCAA) sports are injured every year, according to a five-year study published by the Centers for Disease Control and Prevention in 2015.

Researchers found high injury rates across many of the sports kicking off this fall. Among all sports, college football had the highest raw number of injuries – an estimated 47,199 over the five years. It also had one of the highest injury rates of all sports, with 9.2 athletes injured for every 1,000 athlete-exposures to potential injury (one athlete’s participation in one competition or one practice). 

Women’s soccer had the next-highest injury rate among fall sports, with 8.4 injuries per 1,000 athlete-exposure. Among all sports, men’s wrestling had the highest injury rate, at 13.1 injuries per 1,000 athlete-exposures. Women’s gymnastics, at 10.4 injuries per 1,000 athlete exposures, had the greatest injury rate among women’s sports.

Almost one out of four athlete injuries required more than seven days of recuperation before the athlete could return to practice or competition. Nearly half (45%) of all injuries were sprains and strains, and of those injuries, about one in four required a week of recuperation.  

ZetrOZ Systems’ sustained acoustic medicine (sam®) technology is proven to reduce the recovery period for those kinds of soft-tissue injuries. More than 40 clinical studies have shown that the ZetrOZ sam® X1 and 2.0 devices reduce pain and improve function without using invasive surgery or potentially addictive painkillers. 

“We work with college athletic trainers nationwide, and we know that our sam® devices help heal athletes’ soft-tissue injuries more quickly and help players return to practices and games sooner,” said Dr. George K. Lewis, founder and CEO of ZetrOZ Systems.  

A 2022 study, by authors that included three respected college athletic trainers, examined sam® usage by 239 healthcare providers for treating injuries to tendons and ligaments, joints, large muscle groups, and bone. They reported that sam® provided clinical improvement in under two weeks in more than two-thirds of cases (68.9%) and resulted in a 50% reduction in pain medication. The study concluded sam® is an “effective, safe, easy-to-use, noninvasive, comfortable, and versatile therapeutic for healing musculoskeletal injuries.”

In addition, a 2022 article published in Open Orthopedics Journal surveyed athletic trainers working in professional, collegiate, and military sports medicine to evaluate ZetrOZ’s sam® technology. The study found that sam® is a “fast, simple topical application yielding rapid healing without causing additional trauma to suffering athletes.” The study also included follow-up interviews with the athletic trainers. The researchers reported that “Candid input from professional athletic and military ATs shows a consensus that sam® is a superior healing technology.”

A 2015 level 4 clinical study by sports medicine experts at Ohio State University and Duke University found sustained acoustic medicine delivered via ZetrOZ’s sam® reduced pain and improved strength in patients’ medial/lateral elbow tendons and Achilles tendons. 

Sustained acoustic medicine works by increasing blood vessel diameters to improve blood flow. That increases oxygenated hemoglobin at the therapy site and removes cytokine enzymes and cellular waste, resulting in more rapid healing and reduced pain.

ZetrOZ’s sam® devices are the only FDA-cleared wearable ultrasound units approved for daily use at home. ZetrOZ’s technology was developed, in part, with funding from the National Institute of Health, National Science Foundation, Department of Defense, and NASA. ZetrOZ Systems products are designed and manufactured in the United States and are protected by 46 U.S. patents.   

To learn more, visit www.samrecover.com.

About ZetrOZ Systems   

ZetrOZ Systems is leading healing innovations in sports medicine, developing wearable bioelectronic devices for the delivery of sustained acoustic medicine (sam®). Researched and funded by the federal government, ZetrOZ is built on the proprietary medical technology of +46 patents and is the exclusive manufacturer and developer of the sam® product line, which is designed for the treatment of acute and chronic musculoskeletal conditions. 

Contact Information:

Maria Penaloza

[email protected]

Original Source:

ZetrOZ Systems’ sam Technology Can Help College Athletes Recover From Injury

The post ZetrOZ Systems’ sam Technology Can Help College Athletes Recover From Injury appeared first on AESTHETIC NEWS.

CLS Health Acquires Southeast Houston Cardiology, Expanding Cardiology Services

CLS Health Acquires Southeast Houston Cardiology, Expanding Cardiology Services

September 13, 2023 Editor 0

CLS Health Acquires Southeast Houston Cardiology, Expanding Cardiology Services

CLS Health Acquires Southeast Houston Cardiology, Expanding Cardiology ServicesThe acquisition enhances patient care and extends CLS Health’s geographical reach in the Houston area.

CLS Health Acquires Southeast Houston Cardiology, Expanding Cardiology Services
Southeast Houston Cardiology & CLS Health

CLS Health completes acquisition of Southeast Houston Cardiology

CLS Health, formerly known as Clear Lake Specialties, has finalized the acquisition of Southeast Houston Cardiology, a leading cardiology practice. This move is part of CLS Health’s strategic expansion in the Houston metropolitan area and comes shortly after its recent merger with Clear Lake Cardiovascular Consultants. 

Strategic Alignment and Patient Care 

“The acquisition of Southeast Houston Cardiology allows us to offer specialized cardiac care to our growing patient base of over 80,000. It aligns perfectly with our strategic priorities of geographical expansion and providing comprehensive healthcare,” says Dr. Mohammad Baba, President of CLS Health. “In a market that is being invaded by outside venture capitalists and insurance companies, CLS Health allows our community’s doctors to preserve their independence and their ability to provide excellent healthcare.” 

“Partnering with CLS Health allows us to better serve the Houston community. It’s a positive step for both practices,” says Dr. David Hamer, Founder of Southeast Houston Cardiology.

Operational Excellence and Community Impact 

Immediate plans include utilizing CLS Health’s resources to improve operations, offer more in-house ancillary services, and connect patients to a larger network. “Both CLS Health and Southeast Houston Cardiology have a long-standing commitment to community healthcare,” said Dr. Dweik, Vice President. “With this acquisition, we’re putting specialized, compassionate cardiac care within easy reach of those who live and work in these rapidly growing communities.” 

Future Outlook and New Facilities 

This acquisition comes on the heels of CLS Health’s newest 100,000-square-foot planned addition to its main campus at 600 North Kobayashi Road, Webster, which will include a cardiac catheterization laboratory and an ambulatory surgery center. “The new facilities at our main campus and this acquisition are synergistic steps to provide comprehensive cardiac care across the Greater Houston area,” added Shahbaz Rabbani, Director of Operations, CLS Health. 

Leadership in Cardiology 

Combined with the prior merger with Clear Lake Cardiovascular Consultants, these strategic moves position CLS Health at the forefront of Houston’s cardiology footprint. “With more than 15 providers, Cardiology has become CLS Health’s second-largest service line, only behind primary care,” noted Shahbaz Rabbani, Director of Operations, CLS Health. 

About CLS Health 

CLS Health, formerly known as Clear Lake Specialties, is a leading multispecialty group practice founded with the mission to provide comprehensive and specialized medical care in the Greater Houston area. Our team comprises over 160+ physicians and allied health professionals who practice across 23 locations, offering medical services in 30+ specialties. For more information, visit cls.health.

Contact Information:

Isaiah Rincon

Media Relations Manager

[email protected]

8328587307

Original Source:

CLS Health Acquires Southeast Houston Cardiology, Expanding Cardiology Services

The post CLS Health Acquires Southeast Houston Cardiology, Expanding Cardiology Services appeared first on AESTHETIC NEWS.